Clinical trial Recruiting at 1 site Observational Ages 18 to 90

Examining the oral bacteria in elderly people with and without Alzheimer's disease

Official title: Oral Bacterial and Viral Mapping by Dental Plaque in Elderly Patients With and Without Alzheimer's Disease(ORal MICrobiology in Alzheimer's Patients)

Run by Centre Hospitalier Universitaire de Nice · NCT05077618 · Data updated 2026-11-12

This study is trying to see if the types of bacteria in the mouths of older adults can help us understand more about Alzheimer's disease by comparing those with the condition to those without it.

More Alzheimer Disease trials

Quick facts

Study typeObservational
Ages18 Years to 90 Years
SexAll
Enrollment94 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Nice, CHU de NICE)
StatusRecruiting
StartedJanuary 30, 2023
Main results expectedJanuary 30, 2023
Study endsJuly 31, 2025
Registry record updatedMarch 20, 2025
Trial IDNCT05077618 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are elderly individuals aged 70 and older, with a diagnosis of possible or probable Alzheimer's disease.

Probably not a fit

Patients with other neurodegenerative disorders or significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to analyze the periodontal microbiota in elderly individuals, specifically focusing on those diagnosed with Alzheimer's disease compared to those without. By collecting dental plaque and blood samples, researchers hope to identify oral infectious markers that may indicate the development or progression of neurodegenerative diseases. The study seeks to map the oral microbial flora to enhance understanding and potentially control the evolution of Alzheimer's disease. The ultimate goal is to characterize oral pathogens significantly associated with Alzheimer's.

Why it matters

Potential benefit: If successful, this study could lead to early diagnostic markers for Alzheimer's disease through oral health assessments.

How similar studies have gone: While the approach of linking oral health to neurodegenerative diseases is gaining interest, this specific study's methodology is relatively novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ge greater than or equal to 70 years old
* Patient (or trusted person) having read and understood the study information note and signed the informed consent form
* Membership in a social security scheme
* for cases : Diagnosis of possible or probable Alzheimer's disease according to the DSM-V

Exclusion Criteria:

* Presence of a neurodegenerative pathology (excluding Alzheimer's disease for cases)
* Presence of a neurocognitive disorder (excluding Alzheimer's disease for the cases)
* Patient with or having had any kind of cancer, including oral or aerodigestive tract
* Patients with or having had autoimmune diseases (HIV, hepatitis)
* Patients with inflammatory diseases (such as rheumatoid arthritis (RA) or Gougerot-Sjogren's syndrome (GSJ))
* Patients with severe haemopathy
* Patients with severe acute or chronic cardiovascular, renal, hepatic, gastrointestinal, allergic, endocrine, pulmonary, neuropsychiatric pathologies, judged by the investigator to be incompatible with the study, as all these pathologies may interfere with the results of the oral flora sampling
* Patients who have undergone oral surgery in the two months prior to sampling
* Patients treated with oral retinoids, bisphosphonates, oral anticoagulants or anticonvulsants
* Patients who have had anti-cancer or immunosuppressive chemotherapy within the last 6 months
* Patient who has had antibiotic or anti-inflammatory treatment in the last 4 weeks
* A history of treatments (drugs and probiotics) taken in the month prior to sampling will be taken, as well as a record of toxic habits (tobacco, alcohol, other)

Where it's running

  • CHU de Nice
    Nice, CHU de NICE, France
    Recruiting

Study contacts

  • Principal investigator: Leslie BORSA — Centre Hospitalier Universitaire de Nice
  • Study coordinator: Leslie Borsa
  • Email: causeret.m@chu-nice.fr
  • Phone: 0492034702

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.